therapeutic horseshoe

Trading Markets (press release) - Los Angeles,CA,USA

Jul 29, 2008 - Hy'bred International, Inc. (PINK SHEETS: HYII), a manufacturer of a patent-pending therapeutic horseshoe, announced today the national expansion of the company. Stated Gary Kouletas, Founder and President of Hy'bred, "Financial projections call for $5 million in sales by the second or third year. The potential is vast, with 9 million horses in the United States and 50 million in the world. To reach their owners, Hybred has a marketing agreement with Thoro'bred Inc., the nation's biggest aluminum horseshoe manufacturer." Kouletas spent five years designing and perfecting a horse shoe which has succeeded where others of its kind have failed. Essentially, the company has created a binding process that securely adheres a polyurethane inset to the basic metal horseshoe, thus making the shoe more durable and beneficial to the horse. Hoof injuries are the number one problem in the equine industry, accounting for nearly 90 percent of all potentially serious injuries to horses. The company believes its product to be a cost-effective, practical alternative to traditional equestrian industry shoeing methods.